Low AMH and IVF: What Ovarian Reserve Means for Treatment Planning

Low anti-Müllerian hormone, or AMH, can suggest a lower number of recruitable eggs, but it does not mean pregnancy is impossible. In IVF planning, AMH is interpreted alongside age, ultrasound findings, previous treatment response and personal goals.

Overview

Anti-Müllerian hormone, usually called AMH, is a hormone produced by small developing follicles in the ovaries. Because these follicles represent part of the remaining egg supply, AMH is commonly used as a blood test marker of ovarian reserve. In fertility care, ovarian reserve means the expected quantity of eggs that may be available for recruitment, not a direct measure of whether a person can become pregnant naturally.

Low AMH and IVF planning often go together because AMH helps fertility specialists estimate how many eggs may be collected during ovarian stimulation. A lower AMH level may mean fewer follicles respond to fertility medicines, which can lead to fewer eggs retrieved. However, the number on the report is only one part of the picture, and it should be interpreted carefully by a reproductive medicine specialist.

For many patients, hearing that AMH is low can feel discouraging. A balanced understanding is important: low AMH does not mean there are no eggs, and it does not automatically mean IVF cannot work. It does suggest that treatment decisions should be individualized, timely and realistic, with attention to age, ultrasound findings, previous cycles, partner or sperm factors and overall health.

What AMH Can and Cannot Tell About Fertility

AMH is most helpful for predicting ovarian response during IVF. People with higher AMH often produce more follicles during stimulation, while people with lower AMH may produce fewer. This information helps doctors choose medication type, starting dose, monitoring frequency and whether additional strategies should be discussed before treatment begins.

AMH does not directly measure egg quality. Egg quality is closely related to age, especially the chance that an egg has the correct number of chromosomes. A younger patient with low AMH may produce fewer eggs but may still have a reasonable chance of obtaining a healthy embryo, while an older patient with normal AMH may still face age-related egg quality challenges.

AMH is also not a perfect predictor of natural conception. Some people with low AMH conceive without IVF, especially if they ovulate regularly and there are no major sperm, tubal or uterine factors. Conversely, a normal AMH result does not guarantee fertility. For this reason, AMH is best used as one tool within a complete fertility assessment rather than as a stand-alone diagnosis.

Symptoms, Causes and Risk Factors for Low AMH

Low AMH itself usually does not cause symptoms. Many people discover it during fertility testing, before egg freezing, or after trying to conceive for several months. Menstrual cycles may still be regular even when ovarian reserve is reduced, although very irregular or absent periods can point to other hormonal conditions that need evaluation.

The most common reason for declining AMH is age, because the number of eggs naturally decreases over time. AMH typically falls gradually as ovarian reserve declines, though the pace varies widely from person to person. Genetics also play a role; some individuals naturally have a lower ovarian reserve at a younger age.

Other factors may be associated with low AMH or diminished ovarian reserve. These can include previous ovarian surgery, endometriosis involving the ovaries, chemotherapy or pelvic radiotherapy, autoimmune conditions, smoking, certain genetic conditions and a family history of early menopause. Sometimes no clear cause is found.

• Low AMH should be interpreted with an antral follicle count on ultrasound when possible.
• Very high AMH may suggest a different situation, such as polycystic ovary syndrome, which requires a different treatment approach.
• Any single abnormal result may need repeat testing or confirmation depending on the laboratory and clinical context.

How Ovarian Reserve Is Assessed Before IVF

A fertility evaluation usually includes more than one test. AMH can be checked on most days of the menstrual cycle, which makes it convenient. Doctors may also request early-cycle follicle-stimulating hormone, or FSH, and estradiol levels. These hormones provide additional information about how hard the brain is working to stimulate the ovaries.

Transvaginal ultrasound is another key part of assessment. During ultrasound, the doctor counts small resting follicles in both ovaries; this is called the antral follicle count, or AFC. The AFC often correlates with AMH and helps confirm whether the ovaries are likely to produce a low, average or high number of eggs during IVF stimulation.

A complete plan also considers the uterus, fallopian tubes when relevant, ovulation history, thyroid and prolactin status, genetic considerations, previous pregnancies and the sperm analysis. In couples or individuals seeking care for female infertility, identifying all contributing factors is important because low AMH may not be the only reason conception has been difficult.

IVF Treatment Planning With Low AMH

In IVF treatment, the ovaries are stimulated with fertility medications so that more than one follicle may mature in the same cycle. With low AMH, the goal is often to make the most of the follicles available rather than expecting a high egg number. Doctors may individualize the protocol, adjust medication doses, choose different stimulation schedules, or consider adding specific supportive medicines when appropriate.

It is important to know that increasing medication beyond a certain point does not always produce more eggs. If the ovarian reserve is low, the ovary may have only a small group of follicles available in that cycle. Careful monitoring with blood tests and ultrasound helps the team decide when to trigger ovulation and proceed with egg retrieval.

Fewer eggs retrieved can mean fewer embryos available for transfer or freezing, but quality still matters. Some patients with low AMH obtain one or a few embryos and may still have a chance of pregnancy. If sperm quality is reduced or if previous fertilization has been poor, ICSI may be considered, where a single sperm is injected into each mature egg in the laboratory.

Some patients may need more than one cycle to collect embryos, particularly if they are pursuing embryo freezing or genetic testing. Others may discuss alternatives such as modified natural-cycle IVF, donor eggs, or stopping treatment after a realistic review of chances and burdens. The best plan is individualized, medically safe and aligned with the patient’s values.

Interpreting Chances of Success

IVF success with low AMH depends on several factors, and age is one of the most important. AMH helps estimate egg number, but age strongly influences the likelihood that an egg can form a chromosomally normal embryo. This is why two people with the same AMH may receive different counselling and treatment recommendations.

Previous response to fertility medication is also valuable. If a patient has already completed an IVF cycle, the number of follicles, mature eggs, fertilized eggs and embryo development provide direct information for future planning. A cycle with few eggs is not always a failure, but it can help refine the next approach.

Doctors may also discuss whether embryo transfer should occur in the same cycle or after freezing, depending on embryo development, hormone levels and uterine readiness. In some cases, preimplantation genetic testing may be discussed, particularly for age-related chromosome concerns, although it is not suitable or necessary for every patient. Patients should receive individualized counselling about possible benefits, limitations and costs before deciding.

Self-Care, Lifestyle and Emotional Support

No lifestyle change can restore ovarian reserve to an earlier level, but general health can support fertility treatment and pregnancy readiness. Patients are usually encouraged to stop smoking, limit alcohol, avoid recreational drugs, maintain a healthy weight when possible and review medications or supplements with a doctor. A nutritious diet, regular physical activity and adequate sleep may help overall wellbeing during treatment.

Some supplements are marketed for low AMH, but evidence varies, and not all products are safe or useful for every person. Patients should avoid starting high-dose supplements, hormones or alternative therapies without medical advice, especially during IVF. A fertility specialist can explain which options may be reasonable and which may interfere with treatment.

The emotional side of low AMH can be significant. Patients may feel pressure to make quick decisions, compare their results with others, or worry about the future. Counselling, support groups and clear communication with the fertility team can help patients process information and make decisions at a pace that is medically appropriate and emotionally manageable.

When to See a Fertility Specialist

A person should consider seeing a fertility specialist if they have been trying to conceive for 12 months without success, or after 6 months if they are 35 or older. Earlier assessment is reasonable for anyone with known low AMH, irregular or absent periods, previous ovarian surgery, endometriosis, recurrent pregnancy loss, a history of chemotherapy or radiotherapy, or a partner with abnormal sperm results.

Patients who are not currently trying to conceive but are concerned about future fertility may also benefit from counselling. AMH testing and ultrasound can help guide discussions about timing, egg freezing or embryo freezing, while also setting realistic expectations. The result should be explained in context rather than used alone to predict the future.

Acibadem International’s multidisciplinary fertility specialists and JCI-accredited hospitals evaluate and treat infertility for international patients, including those with low ovarian reserve. As with any fertility decision, patients should seek a qualified medical opinion that includes a complete assessment, individualized counselling and a clear discussion of risks, benefits and alternatives.

Frequently asked questions

Does low AMH mean IVF will not work?

No. Low AMH often means the ovaries may produce fewer eggs during stimulation, but it does not mean IVF cannot work. Age, egg quality, sperm factors, embryo development and uterine health all influence the chance of pregnancy.

Can AMH levels be increased?

There is no proven treatment that reliably restores ovarian reserve or permanently raises AMH in a way that improves fertility outcomes. Some lifestyle steps can support general reproductive health, but they cannot create new eggs. Any supplements or medications should be discussed with a fertility specialist.

What AMH level is considered low?

The meaning of an AMH result depends on the laboratory, the units used, age and clinical context. A value that is low for one age group may be interpreted differently in another. Patients should ask their doctor to explain the result together with ultrasound findings and other tests.

Is IVF always the best option for low AMH?

Not always. IVF may be recommended when time is important, when there are additional infertility factors, or when previous attempts have not worked. Some patients may try other approaches, while others may consider egg or embryo freezing, donor eggs, or individualized alternatives.

Can someone get pregnant naturally with low AMH?

Yes, natural pregnancy can occur with low AMH, especially if ovulation is regular and there are no major sperm, tubal or uterine problems. AMH is better at predicting response to IVF medication than predicting natural conception. Age and how long the person has been trying are important when deciding whether to seek treatment.

Should AMH be repeated before starting IVF?

Sometimes it may be repeated, especially if the result does not fit the ultrasound picture or if testing was done at a different laboratory. However, treatment decisions usually rely on the full fertility assessment, not AMH alone. A specialist can advise whether repeat testing would change the plan.

References

• European Society of Human Reproduction and Embryology
• American Society for Reproductive Medicine
• National Institute for Health and Care Excellence
• American College of Obstetricians and Gynecologists
• World Health Organization

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.